Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.
El-Akel W, El-Sayed MH, El Kassas M, El-Serafy M, Khairy M, Elsaeed K, Kabil K, Hassany M, Shawky A, Yosry A, Shaker MK, ElShazly Y, Waked I, Esmat G, Doss W. El-Akel W, et al. Among authors: shaker mk. J Viral Hepat. 2017 Apr;24(4):262-267. doi: 10.1111/jvh.12668. Epub 2017 Feb 1. J Viral Hepat. 2017. PMID: 28145032 Review.
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.
Omar H, El Akel W, Elbaz T, El Kassas M, Elsaeed K, El Shazly H, Said M, Yousif M, Gomaa AA, Nasr A, AbdAllah M, Korany M, Ismail SA, Shaker MK, Doss W, Esmat G, Waked I, El Shazly Y. Omar H, et al. Among authors: shaker mk. Aliment Pharmacol Ther. 2018 Feb;47(3):421-431. doi: 10.1111/apt.14428. Epub 2017 Nov 29. Aliment Pharmacol Ther. 2018. PMID: 29193226
High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study.
Darweesh SK, Elsaeed K, Omar H, El Raziky M, Elakel W, Elserafy M, Ismail SA, Gomaa AA, Mehrez M, El Kassas M, Abdullah M, Shaker MK, Esmat G, El Shazly Y, Doss W, Waked I. Darweesh SK, et al. Among authors: shaker mk. Expert Rev Gastroenterol Hepatol. 2019 Sep;13(9):907-914. doi: 10.1080/17474124.2019.1629287. Epub 2019 Jun 23. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31173527
Effectiveness of combined therapy radiofrequency ablation/transarterial chemoembolization versus transarterial chemoembolization/radiofrequency ablation on management of hepatocellular carcinoma.
El Dorry AK, Shaker MK, El-Fouly NF, Hussien A, El-Folly RF, El Fouly AH, Abd El Tawab K. El Dorry AK, et al. Among authors: shaker mk. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(12):1573-1577. doi: 10.1097/MEG.0000000000001878. Eur J Gastroenterol Hepatol. 2021. PMID: 32796363
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma.
Omar A, Kaseb A, Elbaz T, El-Kassas M, El Fouly A, Hanno AF, El Dorry A, Hosni A, Helmy A, Saad AS, Alolayan A, Eysa BE, Hamada E, Azim H, Khattab H, Elghazaly H, Tawfik H, Ayoub H, Khaled H, Saadeldin I, Waked I, Barakat EMF, El Meteini M, Hamed Shaaban M, EzzElarab M, Fathy M, Shaker M, Sobhi M, Shaker MK, ElGharib M, Abdullah M, Mokhtar M, Elshazli M, Heikal OMK, Hetta O, ElWakil RM, Abdel Wahab S, Eid SS, Rostom Y; Egyptian Liver Cancer Committee Study Group. Omar A, et al. Among authors: shaker mk. J Hepatocell Carcinoma. 2023 Sep 18;10:1547-1571. doi: 10.2147/JHC.S404424. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37744303 Free PMC article. Review.
Direct-acting antiviral regimens in Egyptian patients with chronic hepatitis C virus infection: A real-world single-center experience.
Naguib GG, Farid A, Hassan M, Elshafie A, Shazly YE, Shaker MK, Ezzat H, Safwat E, Ahmed OA, Dabbous H, Sherief AF, Hassany M, Elserafy M, Elsayed MH. Naguib GG, et al. Among authors: shaker mk. Arab J Gastroenterol. 2021 Dec;22(4):285-291. doi: 10.1016/j.ajg.2021.06.001. Epub 2021 Sep 13. Arab J Gastroenterol. 2021. PMID: 34531135
20 results